Avendaño RM

Language: Spanish
References: 6
Page: 368-369
PDF size: 60.33 Kb.

Text Extraction

No Abstract

REFERENCES

1. Poland GA, Jacobson RM. Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004; 351: 2832-8.

2. Harpaz R, MacMahon BJ, Margolis HS, et al. Elimination of new chronic hepatitis B virus infection: results of the Alaska immunization program. J Infect Dis 2000; 181: 413-18.

3. Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135: 796-800.

4. Yvonnet B, Coursaget P, Chotard J, et al. Hepatitis B vaccine in infants from an endemic area: long term anti HbsAg persistence and revaccination. J Med Virol 1987; 22: 315-21.

5. Ding L, Zhang M, Wang Y, et al. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma derived hepatitis B vaccine in high-risk Chinese neonates. Clin Infect Dis 1993; 17: 475-9.

6. Hadler SC, Francis DP, Maynard JE, et al. Long–term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986; 315: 209-14.